Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
NCT03728829
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Observational
Prospective
Interventions
DRUG:
Trastuzumab+TP
Sponsor
Hebei Medical University Fourth Hospital
Collaborators
[object Object]